This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Ahuva Nissim, Ph.D.
Prof in Antibody and Therapeutic Engineering at Queen Mary University
Speaker

Profile

Ahuva Nissim graduated in Molecular Immunology in 1992 from the Weizmann Institute of Science in Rehovot and was trained as a postdoctoral fellow at the MRC Centre for Protein Engineering in Cambridge until 1995. She built phage display semi-synthetic human antibody library, the so call ‘Nissim’ library which has been used worldwide. Her current studies at Queen Mary University are interdisciplinary and involve autoimmune diseases and oncology. Mostly focusing on the mechanisms that lead to the formation of disease tissue-specific neoepitopes and their exploitation for novel disease - and tissue-specific, diagnosis and targeted treatment.

Agenda Sessions

  • Leveraging Formation of Post-translationally Modified Neoepitopes to Targeting Therapeutic Specifically to Diseased Tissue

    2:30pm